Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1384101/000138410118000074/vcyt1026188-k.htm
December 2022
November 2022
August 2022
August 2022
June 2022
May 2022
February 2022
February 2022
January 2022
November 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1384101/000138410118000074/vcyt1026188-k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Veracyte, Inc..
Veracyte, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: VCYTEvents:
CIK: 1384101
Form Type: 8-K Corporate News
Accession Number: 0001384101-18-000074
Submitted to the SEC: Fri Oct 26 2018 6:29:15 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Medical Laboratories